| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |